Health Net
Zinbryta (daclizumab)
Drugs for the Nervous System : Drugs for Multiple Sclerosis
  • Prior Authorization: Multiple Sclerosis (MS):
    Documented Diagnosis: Yes
    Duration: 1 plan year
    Reauthorization Required: Yes

  • Step Therapy: Multiple Sclerosis (MS):
    ST Multiple Brands

  • Multiple Sclerosis (MS):
    Duration: 1 plan year
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 plan year
    Patients Cardiac Medical History Required: No
    Concomitant use of other MS medication: No